Treasurer of the State of North Carolina
VRTX icon

Treasurer of the State of North Carolina’s Vertex Pharmaceuticals VRTX Stock Holding History

Treasurer of the State of North Carolina’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.5M Buy
108,663
+905
+0.8% +$422K 0.15% 114
2025
Q4 		$48.9M Sell
107,758
-7,871
-7% -$3.39M 0.16% 111
2025
Q3 		$45.3M Sell
115,629
-4,505
-4% -$1.88M 0.14% 128
2025
Q2 		$53.5M Buy
120,134
+1,759
+1% +$811K 0.17% 102
2025
Q1 		$57.4M Buy
118,375
+1,582
+1% +$737K 0.23% 83
2024
Q4 		$47M Buy
116,793
+520
+0.4% +$241K 0.18% 94
2024
Q3 		$54.1M Sell
116,273
-15,646
-12% -$7.52M 0.22% 83
2024
Q2 		$61.8M Buy
131,919
+1,180
+0.9% +$512K 0.26% 65
2024
Q1 		$54.6M Sell
130,739
-867
-0.7% -$367K 0.24% 81
2023
Q4 		$53.5M Sell
131,606
-717
-0.5% -$265K 0.26% 76
2023
Q3 		$46M Sell
132,323
-715
-0.5% -$250K 0.25% 79
2023
Q2 		$46.8M Sell
133,038
-62
-0% -$20.9K 0.25% 80
2023
Q1 		$41.9M Buy
133,100
+1,535
+1% +$460K 0.24% 87
2022
Q4 		$38M Buy
131,565
+5,844
+5% +$1.78M 0.23% 93
2022
Q3 		$36.4M Buy
125,721
+549
+0.4% +$158K 0.24% 80
2022
Q2 		$35.3M Buy
125,172
+7,597
+6% +$2.03M 0.22% 88
2022
Q1 		$30.7M Buy
117,575
+2,691
+2% +$639K 0.17% 118
2021
Q4 		$25.2M Buy
114,884
+1,673
+1% +$325K 0.13% 151
2021
Q3 		$20.5M Buy
113,211
+310
+0.3% +$60.5K 0.12% 162
2021
Q2 		$22.8M Sell
112,901
-950
-0.8% -$199K 0.13% 157
2021
Q1 		$24.5M Buy
113,851
+400
+0.4% +$87.9K 0.15% 134
2020
Q4 		$26.8M Buy
113,451
+510
+0.5% +$117K 0.18% 122
2020
Q3 		$30.7M Buy
112,941
+430
+0.4% +$119K 0.23% 83
2020
Q2 		$32.7M Sell
112,511
-12,450
-10% -$3.38M 0.27% 73
2020
Q1 		$29.7M Buy
124,961
+10,400
+9% +$2.39M 0.26% 81
2019
Q4 		$25.1M Buy
114,561
+1,160
+1% +$235K 0.21% 114
2019
Q3 		$19.2M Sell
113,401
-47,070
-29% -$8.33M 0.17% 140
2019
Q2 		$29.4M Buy
160,471
+48
+0% +$8.39K 0.18% 128
2019
Q1 		$29.5M Buy
160,423
+2,509
+2% +$463K 0.19% 117
2018
Q4 		$26.2M Buy
157,914
+79
+0.1% +$13.7K 0.19% 119
2018
Q3 		$30.4M Buy
157,835
+52,818
+50% +$9.41M 0.19% 115
2018
Q2 		$17.8M Buy
105,017
+66,031
+169% +$10.2M 0.18% 129
2018
Q1 		$6.35M Buy
+38,986
New +$6.37M 0.17% 134

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Treasurer of the State of North Carolina's VRTX Position: Q1 2026 in Review

Treasurer of the State of North Carolina increased its Vertex Pharmaceuticals (VRTX) stake by 0.84% in Q1 2026, buying an estimated $422K and bringing the position to 108,663 shares worth $48.5M. The position accounts for 0.15% of the portfolio, ranked #114.

Treasurer of the State of North Carolina first reported a position in VRTX in Q1 2018 and has held it in 33 quarters since. The position peaked at $61.8M in Q2 2024. 1,693 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Treasurer of the State of North Carolina held 108,663 shares of Vertex Pharmaceuticals worth $48.5M as of Q1 2026.
  • Treasurer of the State of North Carolina bought 905 Vertex Pharmaceuticals shares in Q1 2026, an estimated $422K.
  • Vertex Pharmaceuticals made up 0.15% of Treasurer of the State of North Carolina's portfolio in Q1 2026, its #114 holding.
  • Treasurer of the State of North Carolina first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 33 quarters since.
  • Treasurer of the State of North Carolina's Vertex Pharmaceuticals position peaked at $61.8M in Q2 2024.
  • 1,693 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q1 2026, filed 14 May 2026.